Operating income decreased 119.9%
Operating income changed -119.9% from the comparable as-filed period. The change ranks at the 54th percentile of 52 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed -119.9% from the comparable as-filed period. The change ranks at the 54th percentile of 52 prior comparable changes.
Revenue changed -89.5% from the comparable as-filed period. The change ranks at the 67th percentile of 52 prior comparable changes.
Operating margin changed -82225 basis points from the comparable as-filed period. The change ranks at the 60th percentile of 52 prior comparable changes.
Net income changed -159.1% from the comparable as-filed period. The change ranks at the 66th percentile of 67 prior comparable changes.
Research & development changed -40.8% from the comparable as-filed period. The change ranks at the 63th percentile of 52 prior comparable changes.
Stock-based compensation changed -31.8% from the comparable as-filed period. The change ranks at the 46th percentile of 52 prior comparable changes.
SBC / revenue changed +12108 basis points from the comparable as-filed period. The change ranks at the 60th percentile of 52 prior comparable changes.
Cash & equivalents changed -2.5% from the comparable as-filed period. The change ranks at the 0th percentile of 94 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.